No Data
Yirui Biology (300942.SZ): The fully automated testing workstation developed has multiple customers currently progressing in the project.
On October 31, Equity Press reported that Yirui Biology (300942.SZ) stated at an investor relations event that the company has developed a fully automated detection workstation. Currently, multiple customers are progressing with the project, such as some factories of Mengniu have completed validation, and Qingdao Nestle have completed validation and are in the trial phase. Several customers like guangdong yantang dairy have expressed purchasing intentions and are in discussions. The company provides customers with systematic and digital solutions, ensuring the quality of detection, assisting customers in achieving digital transformation of quality control and traceability, cost reduction, and efficiency improvement. Additionally, considering the compatibility of test reagents, the sales of fully automated detection workstations will continue.
Yirui Biotech: Report for the third quarter of 2024
Optimistic Investors Push Shenzhen Bioeasy Biotechnology Co., Ltd. (SZSE:300942) Shares Up 46% But Growth Is Lacking
Yirui Biological (300942.SZ) shareholders Yidari and Yikairui completed shareholding, with a total reduction of 0.7357 million shares.
Yirui Biotechnology (300942.SZ) announced that the shareholders Yidaru and Yikairui have completed the implementation of the shareholding reduction plan, with a total reduction...
Yirui Biology (300942.SZ): The current situation of accounts receivable collection for the company is stable.
Gelonghui September 26th | Yirui Biology (300942.SZ) recently stated during a specific stakeholder research that the company's current accounts receivable repayment situation is stable. Different types and regions of customers have varying repayment cycles for accounts receivable, with government customers being mainly affected by bidding requirements, local fiscal budgets, and other factors. The company also adopts flexible management by prepaying part of the accounts and using various payment modes based on specific customer situations.
Yirui Bioscience (300942.SZ): has successfully opened blank markets in France, Germany, Switzerland, Portugal, Morocco, etc.
Gelonghui, September 14th | Yirui Biology (300942.SZ) stated at the investor relations event that in the first half of 2024, the company has successfully opened up blank markets in France, Germany, Swiss franc, Portugal, Morocco, and achieved widespread recognition and good feedback for dairy product testing products in markets such as Turkey and Brazil. At the same time, the company further develops potential customer groups, improves customer stickiness and satisfaction by accelerating the expansion of international government projects for pesticide residue rapid detection products, and providing customized solutions for testing requirements in different countries and regions.
Revenues Not Telling The Story For Shenzhen Bioeasy Biotechnology Co., Ltd. (SZSE:300942) After Shares Rise 27%No Data
No Data
